Target: An Ultra-Cheap Stock, But Demand Destruction Is Real
Seeking Alpha· 2025-08-20 20:02
I'm a full time value investor and writer who enjoys using classical value ratios to pick my portfolio. My previous working background is in private credit and CRE mezzanine financing for a family office. I'm also a fluent Mandarin speaker in both business and court settings, previously serving as a court interpreter. I have spent a good chunk of my adult working life in China and Asia. I have worked with top CRE developers in the past including The Witkoff Group , Kushner Companies, Durst Organization and ...
Credit Acceptance Named One of PEOPLE Magazine's 100 Companies that Care® for Fourth Consecutive Year
GlobeNewswire News Room· 2025-08-20 20:02
Southfield, Michigan, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been named one of PEOPLE Magazine’s 100 Companies That Care® by Great Place To Work® and PEOPLE magazine for the fourth consecutive year. Credit Acceptance was ranked 44th among the 100 companies that made the list, up 15 spots from last year. “Being named a 'Company That Cares' is an incredible honor because it reflects the heart ...
Invivyd Announces Proposed Public Offering of Common Stock
GlobeNewswire News Room· 2025-08-20 20:01
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Invivyd intends to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the shares of Invivyd common stock sold in the public offering at the public offering price, less underwriting discounts and commissions. All of the shares are being offered by Invivyd. The offe ...
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
GlobeNewswire News Room· 2025-08-20 20:01
– U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II variation MAA for setmelanotide to treat acquired hypothalamic obesity – – Company to host “Commercial Readiness for Acquired Hypothalamic Obesity,” event for investors and analysts on Wednesday, September 24, in Boston – BOSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a c ...
Horizon Bancorp, Inc. Announces Launch of Common Stock Offering
GlobeNewswire News Room· 2025-08-20 20:01
MICHIGAN CITY, Ind., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Horizon Bancorp, Inc. (NASDAQ: HBNC) (“Horizon”), the parent company of Horizon Bank, announced today that it has launched an underwritten public offering of shares of its common stock (the “Offering”). Horizon expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the Offering. Horizon intends to use the net proceeds from the Offering for general corporate purposes, including in s ...
CLEAR, an Official TSA PreCheck® Enrollment Provider, Now Enrolling at More Than 190 Staples Stores Across U.S.
GlobeNewswire News Room· 2025-08-20 20:00
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), an authorized TSA PreCheck® enrollment provider, has increased its TSA PreCheck enrollment and renewal locations to more than 190 Staples U.S. retail stores nationwide. CLEAR’s partnership with Staples, which began in 2024, brings TSA PreCheck enrollment beyond the airport making it even easier for consumers to enroll or renew. These Staples locations complement CLEAR’s 62 airport-based enrollment and renewal locations across the U.S. At the end ...
CLEAR, an Official TSA PreCheck® Enrollment Provider, Now Enrolling at More Than 190 Staples Stores Across U.S.
Globenewswire· 2025-08-20 20:00
Staples locations offer convenient options for consumers to enroll or renew TSA PreCheckNEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), an authorized TSA PreCheck® enrollment provider, has increased its TSA PreCheck enrollment and renewal locations to more than 190 Staples U.S. retail stores nationwide. CLEAR’s partnership with Staples, which began in 2024, brings TSA PreCheck enrollment beyond the airport making it even easier for consumers to enroll or renew. These Staples locations complem ...
MYR Group Inc. to Attend D.A. Davidson 24th Annual Diversified Industrials & Services Conference in September
GlobeNewswire News Room· 2025-08-20 20:00
THORNTON, Colo., Aug. 20, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced it will attend the D.A. Davidson 24th Annual Diversified Industrials & Services investor conference. MYR Group’s Chief Executive Officer, Rick Swartz, and Chief Financial Officer, Kelly Huntington, will meet with institutional inv ...
Shareholders who lost money in shares of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Should Contact Wolf Haldenstein Immediately
GlobeNewswire News Room· 2025-08-20 19:57
New York, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) (“Unicycive or the “Company”) securities between March 29, 2024 and June 7, 2025, inclusive (the “Class Period”). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTA ...
PTC Therapeutics: HD Treatment Advancement Continues With Q4 2025 Catalyst
Seeking Alpha· 2025-08-20 19:53
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...